A postmenopausal patient develops osteoporosis. The patient asks the nurse about medications to treat this condition. The nurse learns that the patient has a family history of breast cancer. The nurse will suggest discussing which medication with the provider?
A) Estrogen estradiol
B) Pamidronate [Aredia]
C) Raloxifene [Evista]
D) Teriparatide [Forteo]

Question

Quizplus · Accepted Answer

Raloxifene is a selective estrogen receptor modulator (SERM) that has estrogenic effects in some tissues and antiestrogenic effects in others. It can preserve bone mineral density while protecting against breast and endometrial cancers. Estrogen promotes breast cancer and would not be indicated. Pamidronate and teriparatide are not protective against breast cancer.

A Postmenopausal Patient Develops Osteoporosis